Posted in | News | Lead | Silver | Zinc

Southern Silver Reports New Assay Results from the Cerro Las Minitas Project in Mexico

Southern Silver Exploration has announced that the latest assays results continue to expand the depth and on-strike projection of silver-polymetallic mineralization at the El Sol and Blind zones on the Cerro Las Minitas project in Durango State, Mexico.

On the El Sol zone, drilling has returned a 26.1 m interval averaging 67 g/t silver, 3.3% zinc and 2.8% lead, including a 1.8 m interval averaging 163 g/t silver, 8.8% zinc and 6.9% lead from 12CLM-044 drill hole. The drill hole tested the target located 50 m to the NW of 11CLM-027 drill hole, which returned 24.8 m of 124 g/t silver, 2.1% zinc and 1.9% lead, and continues to show the lateral extension of this mineralized zone.

On the Blind zone, drilling is presently defining the internal continuity and lateral extent of the mineralized zone. Assay results from the NW zone extension are as follows:

  • A 4.6 m interval averaging 146 g/t silver, 2.8% zinc and 3.0% lead from 12CLM-041 drill hole.
  • A 4.2 m interval averaging 145 g/t silver, 2.0% zinc and 2.7% lead from 12CLM-043 drill hole.

A mineralized interval enriched with silver was discovered in the 12CLM-042 drill hole, which further expanded the strike length of mineralization in the Blind zone to 800 m and stays exposed along strike to the SE.

In 2011, 29 drill holes totaling 8,030 m were concluded. So far, 4630 m in 20 drill holes have been completed in 2012. Assays results from six drill holes are still pending.

Southern Silver Exploration has planned for a 20,000 m of core drilling in 2012, and expects to complete a NI 43-101 compliant resource on the initial group of targets by fourth quarter of 2012.

Source: http://www.southernsilverexploration.com/en/index.php

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Southern Silver Exploration Corp.. (2019, February 18). Southern Silver Reports New Assay Results from the Cerro Las Minitas Project in Mexico. AZoMining. Retrieved on May 19, 2024 from https://www.azomining.com/News.aspx?newsID=6214.

  • MLA

    Southern Silver Exploration Corp.. "Southern Silver Reports New Assay Results from the Cerro Las Minitas Project in Mexico". AZoMining. 19 May 2024. <https://www.azomining.com/News.aspx?newsID=6214>.

  • Chicago

    Southern Silver Exploration Corp.. "Southern Silver Reports New Assay Results from the Cerro Las Minitas Project in Mexico". AZoMining. https://www.azomining.com/News.aspx?newsID=6214. (accessed May 19, 2024).

  • Harvard

    Southern Silver Exploration Corp.. 2019. Southern Silver Reports New Assay Results from the Cerro Las Minitas Project in Mexico. AZoMining, viewed 19 May 2024, https://www.azomining.com/News.aspx?newsID=6214.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.